Long-Term Safety in a Phase 1 Study of Siltuximab (CNTO 328), an Anti-Interleukin-6 Monoclonal Antibody, in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

被引：2

作者：

Kurzrock, Razelle ^{[1
]}

Voorhees, Peter M. ^{[2
]}

Casper, Corey ^{[3
]}

Furman, Richard R. ^{[4
]}

Fayad, Luis ^{[1
]}

Lonial, Sagar ^{[5
]}

Borghaei, Hossein ^{[6
]}

Jagannath, Sundar ^{[7
]}

Sokol, Lubomir ^{[8
]}

Usmani, Saad ^{[9
]}

van de Velde, Helgi ^{[10
]}

Qin, Xiang ^{[11
]}

Qi, Ming ^{[11
]}

Cornfeld, Mark J. ^{[12
]}

van Rhee, Frits ^{[13
]}

机构：

[1] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[4] Cornell Univ, Weill Med Coll, New York, NY 10021 USA

[5] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

[6] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[7] St Vincents Comprehens Canc Ctr, New York, NY USA

[8] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[9] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA

[10] Janssen Res & Dev, Beerse, Belgium

[11] Ortho Biotech Oncol Res & Dev, Malvern, PA USA

[12] Ortho Biotech Oncol Res & Dev, Raritan, NJ USA

[13] Bon Secours St Francis Hlth Syst, Hematol Oncol, Greenville, SC USA

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

10.1182/blood.V118.21.3959.3959

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

页码：1693 / 1693

页数：1

共 50 条

[21] Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma
Frank Neumann
Stefani Harmsen
Simona Martin
Ralf Kronenwett
Mustafa Kondakci
Manuel Aivado
Ulrich Germing
Rainer Haas
Guido Kobbe
Annals of Hematology, 2006, 85 : 530 - 534
[22] Long-Term Results from a Phase 1b Study of Avadomide in Combination with Obinutuzumab in Patients with Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma
Michot, Jean-Marie
Bouabdallah, Reda
Doorduijn, Jeanette K.
Boccomini, Carola
Kersten, Marie Jose
Chiappella, Annalisa
Zinzani, Pier Luigi
Salles, Gilles
Bijou, Fontanet
Hentrup, Mei
Rhee, So Hyun
Hagner, Patrick
Klein, Christian
Pourdehnad, Michael
Hege, Kristen
Dobmeyer, Juergen
Nikolova, Zariana
Ribrag, Vincent
BLOOD, 2020, 136
[23] A Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
Christian, Beth
Kuruvilla, John
Smith, Sonali
Porcu, Pierluigi
Ruppert, Amy S.
Byrd, John C.
Grever, Michael R.
Blum, Kristie A.
BLOOD, 2014, 124 (21)
[24] Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma
Ansell, Stephen M.
Witzig, Thomas E.
Inwards, David J.
Porrata, Luis F.
Ythier, Arnaud
Ferrande, Lee
Nestorov, Ivan
Devries, Todd
Dillon, Stacey R.
Hausman, Diana
Novak, Anne J.
CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1105 - 1110
[25] Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: A preclinical and phase I study
Eisenbeis, CF
Grainger, A
Fischer, B
Baiocchi, RA
Carrodeguas, L
Roychowdhury, S
Chen, L
Banks, AL
Davis, T
Young, D
Kelbick, N
Stephens, J
Byrd, JC
Grever, MR
Caligiuri, MA
Porcu, P
CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6101 - 6110
[26] Treatment of patients with mantle cell and aggressive B-cell non-Hodgkin's lymphoma using the monoclonal anti-CD20 antibody rituximab (Rituxan™):: Evaluation of safety and response.
Winkler, U
Schulz, HR
Klein, TO
Jensen, M
Manzke, O
Schmitz, SH
Rüdiger, T
Müller-Hermelink, KH
Diehl, V
Engert, A
BLOOD, 1999, 94 (10) : 270B - 270B
[27] Tri-lineage disease involving sideroblastic anaemia, multiple myeloma and B-cell non-Hodgkin’s lymphoma in the same patient
Jean-Christophe Ianotto
Adrian Tempescul
Jean-Richard Eveillard
Véronique Marion
Isabelle Quintin-Roué
Christian Berthou
Annals of Hematology, 2009, 88 : 273 - 274
[28] Tri-lineage disease involving sideroblastic anaemia, multiple myeloma and B-cell non-Hodgkin's lymphoma in the same patient
Ianotto, Jean-Christophe
Tempescul, Adrian
Eveillard, Jean-Richard
Marion, Veronique
Quintin-Roue, Isabelle
Berthou, Christian
ANNALS OF HEMATOLOGY, 2009, 88 (03) : 273 - 274
[29] Phase II study of oblimersen sodium and rituximab in patients with recurrent B-cell non-Hodgkin's lymphoma.
Pro, B
Smith, MR
Leber, B
Younes, A
Fayad, L
Hagemeister, FB
McLaughlin, P
Rodriguez, AM
Caddick, Y
Zwiebel, JA
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 587S - 587S
[30] Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma
Forero-Torres, Andres
Chandler, Jason Claud
Iyer, Swaminathan P.
Kanate, Abraham S.
Quinlan, Michelle
Hoever, Petra
Izquierdo, Miguel
Davis, Jaclyn
Madan, Sumit
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1099 - 1109

← 1 2 3 4 5 →